| Refractory hypertension: definition, prevalence, and patient characteristics MC Acelajado, R Pisoni, T Dudenbostel, LJ Dell’Italia, F Cartmill, B Zhang, ... The Journal of Clinical Hypertension 14 (1), 7-12, 2012 | 257 | 2012 |
| Resistant hypertension, obstructive sleep apnoea and aldosterone T Dudenbostel, DA Calhoun Journal of Human Hypertension 26 (5), 281-287, 2012 | 211 | 2012 |
| Refractory hypertension: evidence of heightened sympathetic activity as a cause of antihypertensive treatment failure T Dudenbostel, MC Acelajado, R Pisoni, P Li, S Oparil, DA Calhoun Hypertension 66 (1), 126-133, 2015 | 159 | 2015 |
| Effects of antihypertensive drugs on arterial stiffness T Dudenbostel, SP Glasser Cardiology in Review 20 (5), 259-263, 2012 | 147 | 2012 |
| Refractory hypertension: a novel phenotype of antihypertensive treatment failure T Dudenbostel, M Siddiqui, S Oparil, DA Calhoun Hypertension 67 (6), 1085-1092, 2016 | 102 | 2016 |
| Prevalence and clinical characteristics of refractory hypertension P Armario, DA Calhoun, A Oliveras, P Blanch, E Vinyoles, JR Banegas, ... Journal of the American Heart Association 6 (12), e007365, 2017 | 75 | 2017 |
| Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease R Pisoni, MC Acelajado, FR Cartmill, T Dudenbostel, LJ Dell'Italia, ... Journal of Human Hypertension 26 (8), 502-506, 2012 | 75 | 2012 |
| Management of patients with resistant hypertension: current treatment options N Kumar, DA Calhoun, T Dudenbostel Integrated Blood Pressure Control 6, 139-151, 2013 | 61 | 2013 |
| Resistant and refractory hypertension: antihypertensive treatment resistance vs treatment failure M Siddiqui, T Dudenbostel, DA Calhoun Canadian Journal of Cardiology 32 (5), 603-606, 2016 | 59 | 2016 |
| Use of aldosterone antagonists for treatment of uncontrolled resistant hypertension T Dudenbostel, DA Calhoun American Journal of Hypertension 30 (2), 103-109, 2017 | 57 | 2017 |
| Refractory versus resistant hypertension: Novel distinctive phenotypes T Dudenbostel, M Siddiqui, N Gharpure, DA Calhoun Nature and Science 3 (9), 2017 | 55 | 2017 |
| Body mass index predicts 24-hour urinary aldosterone levels in patients with resistant hypertension T Dudenbostel, L Ghazi, M Liu, P Li, S Oparil, DA Calhoun Hypertension 68 (4), 995-1003, 2016 | 55 | 2016 |
| Both morning and evening dosing of nebivolol reduces trough mean blood pressure surge in hypertensive patients MC Acelajado, R Pisoni, T Dudenbostel, S Oparil, DA Calhoun, ... Journal of the American Society of Hypertension 6 (1), 66-72, 2012 | 46 | 2012 |
| Refractory hypertension is not attributable to intravascular fluid retention as determined by intracardiac volumes A Velasco, M Siddiqui, E Kreps, P Kolakalapudi, T Dudenbostel, G Arora, ... Hypertension 72 (2), 343-349, 2018 | 45 | 2018 |
| Primary aldosteronism and obstructive sleep apnea: is this a bidirectional relationship? A Prejbisz, S Kołodziejczyk-Kruk, JWM Lenders, A Januszewicz Hormone and Metabolic Research 49 (12), 969-976, 2017 | 41 | 2017 |
| Antihypertensive medication adherence and confirmation of true refractory hypertension M Siddiqui, EK Judd, T Dudenbostel, P Gupta, M Tomaszewski, P Patel, ... Hypertension 75 (2), 510-515, 2020 | 33 | 2020 |
| Effect of serum urate lowering with allopurinol on blood pressure in young adults: a randomized, controlled, crossover trial AL Gaffo, DA Calhoun, EJ Rahn, S Oparil, P Li, T Dudenbostel, DI Feig, ... Arthritis & Rheumatology 73 (8), 1514-1522, 2021 | 32 | 2021 |
| Out-of-clinic sympathetic activity is increased in patients with masked uncontrolled hypertension M Siddiqui, EK Judd, BC Jaeger, H Bhatt, T Dudenbostel, B Zhang, ... Hypertension 73 (1), 132-141, 2019 | 32 | 2019 |
| Urinary sodium excretion predicts blood pressure response to spironolactone in patients with resistant hypertension independent of aldosterone status L Ghazi, T Dudenbostel, CP Lin, S Oparil, DA Calhoun Journal of Hypertension 34 (5), 1005-1010, 2016 | 32 | 2016 |
| Urinary sodium predicts blood pressure response to spironolactone in patients with resistant hypertension independent of aldosterone status L Ghazi, T Dudenbostel, S Oparil, D Calhoun J Hypertens 34 (5), 1005-10, 2016 | 32* | 2016 |
Peng LiUniversity of Alabama at BirminghamVerified email at uab.edu
